Quiero saber acerca de...

khammond on DSKJM1Z7X2PROD with RULES2

Federal Register / Vol. 86, No. 116 / Monday, June 21, 2021 / Rules and Regulations some reluctance to get vaccinated Roy et al., December 29, 2020.
Findings in more recent surveys of the general working population from 18 to 65 years old show similar rates of people who stated they would not, probably would not, or would only if required get vaccinated 18.2% Census Bureau, May 5, 2021; 1726% KFF, April 22, 2021. In March 2021, a survey found that healthcare employees reported some of the highest vaccination percentages of any sector 78.3% and 67.7%, respectively; King et al., April 24, 2021. However, future growth of vaccination may be a concern with vaccine hesitation in those sectors reported as 14.1% and 15.9%, respectively.
That unvaccinated healthcare workers remain in grave danger is emphasized by the fact that thousands of new hospital admissions still occur each day CDC, May 24, 2021b in the midst of significant distribution of over three hundred million effective vaccine doses.
These factors indicate that transmission remains robust and significant portions of the population remain vulnerable to COVID19. Spread of the disease within the healthcare workforce may start with a worker becoming ill through community transmission or an ill patient seeking treatment. The rate of new cases, hospitalizations, and deaths peaked in January 2021, just before vaccines became more widely available outside of healthcare settings. The January to February decline, however, is likely not attributable in large part to the new vaccines alone, because only a small portion of the population had received them. During this time, variants of concern, such as B.1.1.7, that are more transmissible and may result in worse health outcomes, have become the majority source of infection CDC, May 24, 2021c. Hundreds of people each day are still dying of COVID19 in early May 2021, many of them workingage adults May 24, 2021d.
OSHA will continue to monitor trends as more of the population becomes vaccinated and the post-vaccine evidence base continues to grow. If and when OSHA finds a grave danger from the virus no longer exists for covered healthcare workplaces or some portion thereof, or new information necessitates a change in measures necessary to address the grave danger, OSHA will update the rule as appropriate.
In summary, the availability and use of safe and effective vaccines for COVID19 is a critical milestone that has led to a marked decrease in risk for healthcare employees generally, but grave danger still remains for those
VerDate Sep<11>2014

21:53 Jun 17, 2021

Jkt 253001

whose jobs require them to work in settings where patients with suspected or confirmed COVID19 receive care.
CDC has determined that the remaining risk for fully vaccinated persons outside of healthcare settings is low enough to justify foregoing other layers of controls for settings where all persons are fully vaccinated and asymptomatic CDC, April 27, 2021, but the CDC continues to recommend respirators and PPE for fully vaccinated healthcare employees in settings where patients with suspected or confirmed COVID19
receive care. Based on CDC guidance and the best available evidence, OSHA
finds a grave danger in healthcare for vaccinated and unvaccinated HCP
involved in the treatment of COVID19
patients.
References Abu-Raddad, LJ et al., 2021, May 5.
Effectiveness of the BNT162b2 Covid19
Vaccine against the B.1.1.7 and B.1.351
Variants. NEJM DOI: 10.1056/
NEJMc2104974 Abu-Raddad et al., May 5, 2021.
Agency for Clinical Innovation ACI. 2021, April 28. Evidence check:
Immunocompromised patients and COVID19 vaccines. https
aci.health.nsw.gov.au/__data/assets/pdf_
file/0009/645750/Evidence-checkImmunocompromised-patients-COVID19-vaccines.pdf. ACI, April 28, 2021.
Agha et al., 2021, April 7. Suboptimal response to COVID19 mRNA vaccines in hematologic malignancies patients.
medRxiv 2021.04.06.21254949. https
doi.org/10.1101/2021.04.06.21254949.
Agha, et al., April 7, 2021.
Baden, L et al., 2021, December 30. Efficacy and safety of the mRNA1273 SARS
CoV2 Vaccine. The New England Journal of Medicine, 3845, 403416.
https doi.org/10.1056/NEJMoa2035389.
Baden et al., December 30, 2020.
Birhane, M et al., 2021, May 28. COVID19
Vaccine Breakthrough Infections Reported to CDCUnited States, January 1April 30, 2021. MMWR 70: 792793.
http dx.doi.org/10.15585/
mmwr.mm7021e3. Birhane et al., May 28, 2021.
Boyarsky, BJ et al., 2021, May 5. Antibody Response to 2-Dose SARSCoV2 mRNA
Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 May 5. doi:
10.1001/jama.2021.7489. PMID:
33950155. Boyarsky et al., May 5, 2021.
Cavanaugh, AM et al., 2021, April 30.
COVID19 outbreak associated with a SARSCoV2 R.1 lineage variant in a skilled nursing facility after vaccination programKentucky, March 2021.
MMWR 70: 639643. http dx.doi.org/
10.15585/mmwr.mm7017e2. Cavanaugh et al., April 30, 2021.
Census Bureau. 2021, May 5. Household Pulse Survey COVID19 Vaccination Tracker. https www.census.gov/library/
visualizations/interactive/householdpulse-survey-covid-19-vaccination-

PO 00000

Frm 00025

Fmt 4701

Sfmt 4700

32399

tracker.html. Census Bureau, May 5, 2021.
Centers for Disease Control and Prevention CDC. 2021, April 2. Science brief:
Background rationale and evidence for public health recommendations for fully vaccinated people. https www.cdc.gov/
coronavirus/2019-ncov/science/sciencebriefs/fully-vaccinated-people.html.
CDC, April 2, 2021.
Centers for Disease Control and Prevention CDC. 2021a, April 27. Updated healthcare infection prevention and control recommendation in response to COVID19 vaccination. https
www.cdc.gov/coronavirus/2019-ncov/
hcp/infection-control-aftervaccination.html. CDC, April 27, 2021a.
Centers for Disease Control and Prevention CDC. 2021b, April 27. Domestic travel during COVID19. https www.cdc.gov/
coronavirus/2019-ncov/travelers/travelduring-covid19.html. CDC, April 27, 2021b.
Centers for Disease Control and Prevention CDC. 2021, May 13. Interim public health recommendations for fully vaccinated people. https www.cdc.gov/
coronavirus/2019-ncov/vaccines/fullyvaccinated-guidance.html. CDC, May 13, 2021.
Centers for Disease Control and Prevention CDC. 2021a, May 24. Demographic Trends of People Receiving COVID19
Vaccinations in the United States.
https covid.cdc.gov/covid-data-tracker/
?CDC_AA_refVal=https%3A%2F%2
Fwww.cdc.gov%2Fcoronavirus%2F2019ncov%2Fcases-updates%2Fcas%
E2%80%A6vaccination-demographic.
CDC, May 24, 2021a.
Centers for Disease Control and Prevention CDC. 2021b, May 24. COVID data tracker. New Admissions of Patients with Confirmed COVID19, United States.
https covid.cdc.gov/covid-data-tracker/
new-hospital-admissions. CDC, May 24, 2021b.
Centers for Disease Control and Prevention CDC. 2021c, May 24. Variant Proportions. https covid.cdc.gov/coviddata-tracker/variant-proportions. CDC, May 24, 2021c.
Centers for Disease Control and Prevention CDC. 2021d, May 24. COVID19
Weekly Deaths per 100,000 Population by Age by Age, Race/Ethnicity, and Sex.
https covid.cdc.gov/covid-data-tracker/
demographicsovertime. CDC, May 24, 2021d.
Dagan, N et al., 2021, February 24.
BNT162b2 mRNA COVID19 vaccine in a nationwide mass vaccination setting. N
Engl J Med. 38415: 14121423. doi:
10.1056/NEJMoa2101765. Epub 2021 Feb 24. PMID: 33626250; PMCID:
PMC7944975. Dagan et al., February 24, 2021.
Deepak, et al., 2021, April 7.
Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARSCoV2. medRxiv 2021.04.05.21254656. https doi.org/
10.1101/2021.04.05.21254656. Deepak et al., April 7, 2021.

E:FRFM21JNR2.SGM

21JNR2